Ashraf S Ibrahim Selected Research

Ashraf S Ibrahim Research Topics

Disease

49	Mucormycosis 04/2024 - 06/2004
42	Infections 04/2024 - 10/2003
11	Candidiasis (Moniliasis) 01/2022 - 02/2005
10	Mycoses (Diseases, Fungus) 04/2024 - 12/2008
5	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2023 - 06/2010
4	Invasive Fungal Infections 11/2023 - 01/2020
4	Vulvovaginal Candidiasis 10/2022 - 01/2018
4	Zygomycosis (Phycomycosis) 02/2009 - 02/2005
3	Diabetes Mellitus 01/2023 - 02/2012
3	Wounds and Injuries (Trauma) 01/2023 - 01/2020
3	Aspergillosis 10/2022 - 04/2011
3	Invasive Pulmonary Aspergillosis 12/2019 - 02/2010
3	Starvation 01/2018 - 09/2007
3	Neoplasms (Cancer) 03/2012 - 02/2010
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 01/2020
2	Necrosis 01/2021 - 11/2006
2	Body Weight (Weight, Body) 01/2020 - 07/2009
2	Fusariosis 01/2020 - 11/2006
2	Acidosis 01/2016 - 12/2014
2	Ketosis 01/2016 - 12/2014
2	Abscess 11/2015 - 12/2014
2	Neutropenia 03/2012 - 02/2012
1	Systemic candidiasis 01/2023
1	Drug-Related Side Effects and Adverse Reactions 10/2022
1	Rhizopus infection 01/2022
1	Tinea (Ringworm) 01/2022
1	Birth Weight (Birth Weights) 01/2022
1	Colitis 01/2021
1	Shock 01/2021
1	scedosporiosis 01/2020

Drug/Important Bio-Agent (IBA)

21	IronIBA 01/2022 - 06/2004
17	liposomal amphotericin B FDA Link 04/2024 - 10/2003
15	VaccinesIBA 01/2021 - 09/2005
12	Proteins (Proteins, Gene)FDA Link 02/2023 - 07/2004
9	posaconazole FDA Link 04/2024 - 02/2009
9	EchinocandinsIBA 10/2022 - 02/2005
8	Deferasirox FDA Link 08/2012 - 09/2007
7	Endoplasmic Reticulum Chaperone BiPIBA 01/2023 - 06/2010
6	Amphotericin B (Amphotericin)FDA LinkGeneric 04/2024 - 04/2008
6	Chelating AgentsIBA 11/2010 - 11/2006
5	LipidsIBA 04/2024 - 04/2008
5	aluminum sulfate (alum)IBA 01/2022 - 01/2011
5	AntibodiesIBA 01/2022 - 01/2011
5	isavuconazoleIBA 01/2021 - 01/2014
5	Caspofungin (Cancidas)FDA Link 08/2008 - 02/2005
4	Deferoxamine (Desferal)FDA LinkGeneric 05/2015 - 11/2006
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
3	AntigensIBA 01/2022 - 01/2006
3	Investigational DrugsIBA 01/2017 - 01/2014
3	Micafungin (FK463)FDA Link 01/2017 - 04/2008
2	ibrexafungerpIBA 04/2024 - 10/2022
2	Membrane Proteins (Integral Membrane Proteins)IBA 08/2023 - 01/2011
2	CytokinesIBA 08/2023 - 04/2021
2	ErbB Receptors (EGF Receptor)IBA 02/2023 - 01/2023
2	Cadherins (E-Cadherin)IBA 02/2023 - 01/2023
2	Monoclonal AntibodiesIBA 01/2023 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2018
2	AzolesIBA 10/2022 - 01/2014
2	Fluconazole (Zonal)FDA LinkGeneric 01/2022 - 10/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 06/2010
2	ProdrugsIBA 01/2020 - 01/2020
2	1-aminobenzotriazoleIBA 01/2020 - 01/2020
2	EnzymesIBA 01/2020 - 01/2017
2	Peptides (Polypeptides)IBA 01/2019 - 01/2011
2	VT-1161IBA 01/2017 - 12/2015
2	Interleukin-22 (IL-22)IBA 11/2015 - 12/2014
2	Interleukin-17 (Interleukin 17)IBA 11/2015 - 12/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2014 - 06/2012
2	PolyenesIBA 04/2011 - 11/2006
2	SiderophoresIBA 12/2008 - 11/2006
1	Ergosterol (Lumisterol)IBA 11/2023
1	Aspartylglucosylaminase (Aspartylglucosaminidase)IBA 08/2023
1	Virulence Factors (Pathogenicity Factors)IBA 01/2023
1	Becaplermin (PDGF-BB)FDA Link 01/2023
1	TriterpenesIBA 10/2022
1	S 27IBA 01/2022
1	alexidineIBA 01/2022
1	HepcidinsIBA 01/2022
1	Ferritins (Ferritin)IBA 01/2022
1	Niclosamide FDA Link 01/2022
1	metal transporting protein 1 (ferroportin)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2022
1	ChemokinesIBA 04/2021
1	RicinIBA 01/2021
1	mucoricinIBA 01/2021
1	jawsamycinIBA 01/2020
1	KetonesIBA 01/2020
1	LigandsIBA 01/2020
1	APX001AIBA 01/2020
1	mannoproteinsIBA 01/2020
1	IntegrinsIBA 01/2020
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2020
1	CalcineurinIBA 01/2020
1	Calcineurin InhibitorsIBA 01/2020

Therapy/Procedure

33	Therapeutics 01/2023 - 02/2005
4	Chelation Therapy (Therapy, Chelation) 03/2012 - 11/2006
3	Salvage Therapy 11/2010 - 12/2008
1	Transplantation 01/2023
1	Drug Therapy (Chemotherapy) 01/2020